title: Use of remifentanil in infants.
abstract: We describe the use of remifentanil in three infants with complex medical issues (hepatic failure, cyanotic heart disease and renal compromise). The short duration of opioid effect even after a long period of drug infusion (18 h) suggests this drug may be useful in some infants. Continued study is warranted.
authors.affiliation: Department of Anesthesiology, University of Washington School of Medicine, Seattle, USA.
authors.forename: J B
authors.initials: JB
authors.lastname: Eck
authors.forename: A M
authors.initials: AM
authors.lastname: Lynn
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D004314:Down Syndrome / Q000503:physiopathology; D004374:Ductus Arteriosus, Patent / Q000150:complications / Q000503:physiopathology / Q000601:surgery; D004694:Endocardial Cushion Defects / Q000150:complications / Q000503:physiopathology; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007442:Intubation, Intratracheal; D007674:Kidney Diseases / Q000150:complications / Q000503:physiopathology; D017093:Liver Failure / Q000150:complications / Q000503:physiopathology; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D000077208:Remifentanil; D012415:Rubinstein-Taybi Syndrome / Q000150:complications / Q000503:physiopathology
chemical_list: D000701:Analgesics, Opioid; D010880:Piperidines; D000077208:Remifentanil